Zepp Health Corp ZEPP
Computer Manufacturing · data as of November 13, 2026
Zepp Health Corp (ZEPP) is a technology company listed in the US with a market value of about $41M. In fiscal year 2025 it had revenue of $259M and net income of -$40M, a net margin of -15.5%.
Its overall Stock Analiz score is 1.0 out of 5 (weak). The strongest part is future growth (3/5); the weakest is track record (0/5).
Key numbers: 5-year revenue growth of -23% a year, a 5-year average ROIC of -6%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 6% above the current price.
About Zepp Health
Zepp Health is listed in the US and classified in computer manufacturing. Revenue went from $138M in 2015 to $259M in 2025, growth of about 6.5% a year. It was profitable in 5 of the last 10 years in our data. It spends 18% of revenue on research and development.
Score: 1.0 / 5
Checks passed
- Price below intrinsic value (DCF, moderate assumptions)
- Revenue growth above 10% last year
- Profit margin improving
- Strong R&D investment or growth above 20%
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- PEG below 1.5
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
- 5-year revenue growth above 8% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $259M | $183M | $351M | $614M | $984M | $984M | $835M | $530M | $315M | $224M |
| Net income | -$40M | -$76M | -$31M | -$43M | $22M | $35M | $83M | $49M | $26M | — |
| Free cash flow | -$26M | -$26M | $41M | -$118M | -$44M | $11M | $57M | $100M | $33M | — |
| EPS (diluted) | $-2.73 | $-5.16 | $-2.12 | $-2.95 | $1.47 | $2.39 | $5.63 | $3.37 | $1.76 | — |
| Net margin | -15.5% | -41.5% | -8.8% | -7.0% | 2.2% | 3.6% | 9.9% | 9.3% | 8.2% | — |
| ROIC | -7.0% | -11.3% | -5.9% | -10.4% | 2.3% | 5.3% | 20.7% | 17.3% | 67.4% | — |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Is Zepp Health stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 6% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Zepp Health pay a dividend?
Not currently.
Is Zepp Health a good stock to buy?
We do not give buy or sell advice. Zepp Health scores 1.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.